Operating environment Temperature has a significant impact on battery discharge performance
Its injected once weekly and is expected to be submitted to the FDA for approval in 2026
Common Side Effects and Management The use of GLP-1 medications, while beneficial for weight management and glycemic control, is often accompanied by side effects such as nausea and gastrointestinal discomfort
Discuss risks/benefits with the provider Medications That May Interact: Diabetes medications (insulin, sulfonylureas): Can increase the risk of hypoglycemia (low blood sugar) Dose adjustments needed Oral hormonal contraceptives (birth control pills): Tirzepatide may decrease effectiveness, especially after the first dose and dose increases Switch to a non-oral contraceptive or add a barrier method for 4 weeks after starting and after each dose increase Other GLP-1 medications: Cannot use tirzepatide with Ozempic, Wegovy, Saxenda, Victoza, Mounjaro, Zepbound, Byetta, or Bydureon Cannot combine with other weight loss medications or supplements without provider approval Mental Health Screening During the telehealth consultation, providers screen for: History of depression Suicidal thoughts or behavior Eating disorders (binge eating disorder, bulimia, and anorexia history) GLP-1 medications carry a warning about suicidal behavior and ideation
The rubber stopper should not be removed, and the vial should only be accessed using appropriate sterile technique with sterile needles and syringes
The type of autoimmune disease depends on the part of the body that's impacted
